MLchartDataset catalogue

levonantradol

Term · Oncology and biomedicine · MLC-T-ONC-014765

A synthetic cannabinoid analogue of delta (9)-tetrahydrocannabinol (delta(9)-THC) with antiemetic and anti-analgesic properties. Although its precise mechanism of action is unknown, levonantradol appears to bind and activate the cannabinoid receptors CB1 and/or CB2.

Table 1. Record
IdentifierMLC-T-ONC-014765
FieldOncology and biomedicine
SynonymsLevonantradol HCl
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-014765",
  "term": "levonantradol",
  "field": "Oncology and biomedicine",
  "definition": "A synthetic cannabinoid analogue of delta (9)-tetrahydrocannabinol (delta(9)-THC) with antiemetic and anti-analgesic properties. Although its precise mechanism of action is unknown, levonantradol appears to bind and activate the cannabinoid receptors CB1 and/or CB2.",
  "synonyms": [
    "Levonantradol HCl"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/levonantradol/"
}

Record 10,065 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.